ThrivePath Medical · Long Beach, California

Benefits

Why patients choose medicinal cannabis, organized by condition, with the formulation direction for each.

Why Patients Choose Cannabis

Areas of therapeutic interest

Patients turn to medicinal cannabis for a wide range of conditions. Tap any area below to learn what patients commonly report and what the research says.

The most common reason patients seek medicinal cannabis. Many report reduced pain intensity and less reliance on other pain medications. Cannabinoids interact with pain receptors in the brain and spinal cord, modulating how strongly pain signals are processed rather than simply masking them.
ThrivePath Formulation Direction
Cannabinoids
THCCBDCBG
Ratio
1:1 THC:CBD2:1 THC:CBD
Terpenes
MyrceneCaryophylleneLinalool
Delivery
TinctureGummiesTopical

A 1:1 THC:CBD ratio addresses pain while CBD moderates psychoactivity. Myrcene and caryophyllene add anti-inflammatory support. Tinctures allow precise dose titration; topical balm for localized joint or muscle pain.

Cannabinoids in focus
  • THCEngages CB1 receptors along pain-processing pathways; patients commonly report reduced pain intensity.
  • CBDNon-intoxicating; interacts with TRPV1 and inflammatory signaling, and can moderate THC’s psychoactivity.
  • CBGEarly research explores CB2-linked anti-inflammatory activity.
Explore the full cannabinoid guide ↓
Cannabinoids interact with CB2 receptors in the immune system, which play a central role in regulating the body's inflammatory response. This is an area of active research for conditions like arthritis, inflammatory bowel disease, and autoimmune conditions where chronic inflammation is the underlying problem.
ThrivePath Formulation Direction
Cannabinoids
CBDCBGCBC
Ratio
CBD dominantNo THC required
Terpenes
CaryophylleneHumulenePinene
Delivery
TinctureTopicalGummies

CBD, CBG, and CBC all target CB2 receptors without psychoactivity. Caryophyllene is the only terpene that directly activates CB2, making it the primary terpene choice here. Topical cream for localized inflammation; tincture or gummies for systemic conditions.

Cannabinoids in focus
  • CBDThe most-studied cannabinoid for inflammation-related signaling, including cytokine modulation.
  • CBGResearch explores immune-cell CB2 interactions and inflammatory response.
  • THCAThe raw, non-intoxicating acid form of THC, studied for anti-inflammatory potential.
Explore the full cannabinoid guide ↓
Patients with insomnia and disrupted sleep commonly explore cannabis to fall asleep more easily and stay asleep longer. Cannabinoids and terpene profiles rich in myrcene and linalool are associated with a settling, sedative quality that many find supports restful sleep without the grogginess of pharmaceutical sleep aids.
ThrivePath Formulation Direction
Cannabinoids
CBNTHCCBD
Ratio
CBN forwardLow-dose THC
Terpenes
MyrceneLinaloolTerpinolene
Delivery
GummiesTincture

CBN is the cannabinoid most associated with sedation. A low-dose THC addition can deepen sleep onset. Myrcene and linalool are the signature sleep terpenes. Gummies taken 60 minutes before bed, or tincture 30 minutes prior for faster onset.

Cannabinoids in focus
  • CBNA mildly sedating oxidation product of THC; the cannabinoid most associated with nighttime formulations.
  • THCCommonly reported to shorten time to fall asleep; dose strongly influences sleep quality.
  • CBDHigher doses are commonly reported as calming, while low doses can be alerting.
Explore the full cannabinoid guide ↓
Many patients use cannabis to ease anxiety and support a steadier mood. CBD works on serotonin receptors and is an area of growing clinical research. The key is formulation: high-THC products can sometimes heighten anxiety in sensitive patients, while CBD-dominant or balanced ratios tend to have a calming effect without intoxication.
ThrivePath Formulation Direction
Cannabinoids
CBDTHCVCBG
Ratio
CBD dominantMinimal THC
Terpenes
LinaloolLimoneneCaryophyllene
Delivery
TinctureDrink

THCV acts as a CB1 antagonist at lower doses, which can help suppress anxiety-driven responses without sedation. CBD-dominant with linalool and limonene creates a calming-yet-clear profile. Tincture allows quick dose adjustment; beverage format suits daytime use.

Cannabinoids in focus
  • CBDInteracts with serotonin 5-HT1A receptors; the most-studied cannabinoid for calm without intoxication.
  • THCBiphasic: low doses are commonly reported as relaxing, while larger doses can heighten anxiety.
  • CBGEarly patient reports explore mood and stress support.
Explore the full cannabinoid guide ↓
Cannabis is one of the most well-documented tools for stimulating appetite and reducing nausea, especially relevant for patients managing chemotherapy side effects, HIV/AIDS wasting, or eating disorders. THC activates CB1 receptors in the brain regions that regulate hunger and nausea response, often producing results where other antiemetics have failed.
ThrivePath Formulation Direction
Cannabinoids
THCCBDACBD
Ratio
THC forwardWith CBDA
Terpenes
LimoneneOcimeneMyrcene
Delivery
TinctureDrink

CBDA is a potent 5-HT1A agonist, the same receptor targeted by prescription anti-nausea medication, and may be more bioavailable than CBD for this use. THC adds appetite support. Tincture or beverage for faster onset, avoiding the stomach disruption of oral capsules when nausea is active.

Cannabinoids in focus
  • THCActs on CB1 receptors in brainstem regions tied to nausea; prescription THC analogs exist for this use.
  • CBDResearch explores serotonin-linked anti-nausea pathways.
  • CBGEarly research explores appetite support.
Explore the full cannabinoid guide ↓
An FDA-approved cannabis-derived medication (Epidiolex) exists specifically for severe seizure disorders. Beyond epilepsy, research into cannabis for multiple sclerosis, Parkinson's, PTSD, and neurodegenerative conditions is active and growing. Schedule III status is expected to significantly accelerate this research in coming years.
ThrivePath Formulation Direction
Cannabinoids
CBDCBDVCBG
Ratio
CBD dominantCondition specific
Terpenes
PineneLinaloolCaryophyllene
Delivery
TinctureGummies

CBDV is in active clinical trials for Rett syndrome and ASD. Pinene may support cognitive clarity and partially offset THC-related memory effects. Neurological conditions vary significantly; ThrivePath recommends physician-guided formulation with consistent dosing tracked over 4-8 weeks.

Cannabinoids in focus
  • CBDA purified CBD medicine is FDA-approved for certain rare seizure disorders.
  • THCStudied for muscle spasticity, notably in multiple sclerosis, where relief is commonly reported.
  • CBCEarly laboratory research explores neuroprotective signaling.
Explore the full cannabinoid guide ↓
Beyond addressing specific symptoms, long-term patient surveys consistently report improvements in overall wellbeing, daily functioning, and subjective quality of life. Many patients describe feeling more present, more comfortable, and better able to engage in daily activities, even when their underlying condition has not resolved.
ThrivePath Formulation Direction
Cannabinoids
CBDCBGLow THC
Ratio
BalancedPatient guided
Terpenes
LimoneneLinaloolPinene
Delivery
TinctureDrinkGummies

Quality-of-life goals benefit from a balanced, adaptable formulation. A daytime-oriented terpene blend with limonene and pinene supports mood and clarity; switching to linalool and myrcene in the evening supports relaxation and sleep. ThrivePath consultants help patients dial in the right morning and evening split.

Cannabinoids in focus
  • THC:CBDGentle balanced ratios are commonly chosen for overall comfort, mood, and daily function.
  • CBGOften called the mother cannabinoid; early research spans mood, comfort, and focus.
  • THCVAmong the minor cannabinoids under active study for targeted effects.
Explore the full cannabinoid guide ↓
Some patients report reducing their use of opioids, benzodiazepines, sleep aids, and other medications after incorporating medicinal cannabis into their care plan. This should always happen under physician supervision, but it is an area of genuine clinical interest, particularly for pain patients looking to reduce opioid dependence.
ThrivePath Formulation Direction
Cannabinoids
CBDTHCCBG
Ratio
1:1 THC:CBDTitrate slowly
Terpenes
MyrceneCaryophylleneLinalool
Delivery
Tincture

Tincture is strongly preferred here - precise dropper dosing is essential when substituting for a pharmaceutical with a known dose. Tapering should always be done under physician supervision. ThrivePath can work with your care team to document formulation, dosing schedule, and response tracking.

Cannabinoids in focus
  • CBDAffects liver CYP450 enzymes that process many common medications; physician guidance is essential.
  • THC:CBDPatients commonly report reducing reliance on other medications under medical supervision, never on their own.
Explore the full cannabinoid guide ↓
No two patients have the same needs, and no single product works for everyone. Different cannabinoid ratios, delivery methods, and terpene profiles suit different conditions and sensitivities. ThrivePath's approach is to understand your specific situation and guide you toward the formulation most likely to help, then adjust from there.
Our Approach to Personalized Formulation
Step 1
Patient intake
Step 2
Formulation match
Step 3
Trial period
Step 4
Adjust and refine

We start with your condition, sensitivity, lifestyle, and goals. We match a cannabinoid ratio, terpene profile, and delivery format to that picture. After a 2-4 week trial, we review and refine. The goal is a formulation that fits your life, not a generic recommendation.

Individual results vary. These statements have not been evaluated by the FDA. Cannabis is not intended to diagnose, treat, cure, or prevent any disease. Always consult a licensed physician about your condition and whether medicinal cannabis is appropriate for you.

See the productsThe science behind it